Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis

Cancer Research

Volumn 71, Issue 13, 2011, Pages 4423-4431

  Banh, Alice ^a   Zhang, Jing ^a   Cao, Hongbin ^a   Bouley, Donna M ^a   Kwok, Shirley ^b   Kong, Christina ^b   Giaccia, Amato J ^a   Koong, Albert C ^a   Le, Quynh Thu ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CARCINOMA CELL; CELLULAR IMMUNITY; CONTROLLED STUDY; HOST CELL; IMMUNOMODULATION; IMMUNOREGULATION; LEWIS CARCINOMA; LUNG CARCINOGENESIS; METASTASIS; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH;

ANIMALS; APOPTOSIS; CARCINOMA, LEWIS LUNG; CELL GROWTH PROCESSES; GALECTIN 1; GENE KNOCKDOWN TECHNIQUES; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; NEOPLASM METASTASIS; T-LYMPHOCYTES;

EID: 79959887879     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-4157     Document Type: Article

References (39)

1. Rabinovich GA, Ilarregui JM. Conveying glycan information into T-cell homeostatic programs: a challenging role for galectin-1 in inflammatory and tumor microenvironments. Immunol Rev 2009;230:144-59.
2. Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat Rev Cancer 2005;5:29-41. (Pubitemid 40052323)
3. Rabinovich GA, Baum LG, Tinari N, Paganelli R, Natoli C, Liu FT, et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?Trends Immunol 2002;23:313-20.
4. Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, et al. Galectins: a family of animal beta-galactoside-binding lectins. Cell 1994;76:597-8. (Pubitemid 24070645)
5. Cleves AE, Cooper DN, Barondes SH, Kelly RB. A new pathway for protein export in Saccharomyces cerevisiae. J Cell Biol 1996;133:1017-26. (Pubitemid 26172507)
6. Seelenmeyer C, Stegmayer C, Nickel W. Unconventional secretion of fibroblast growth factor 2 and galectin-1 does not require shedding of plasma membrane-derived vesicles. FEBS Lett 2008;582:1362-8.
7. Hughes RC. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1999;1473:172-85.
8. Danguy A, Camby I, Kiss R. Galectins and cancer. Biochim Biophys Acta 2002;1572:285-93. (Pubitemid 35246351)
9. Rabinovich GA. Galectin-1 as a potential cancer target. Br J Cancer 2005;92:1188-92. (Pubitemid 40604390)
10. Camby I, Belot N, Rorive S, Lefranc F, Maurage CA, Lahm H, et al. Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol 2001;11:12-26.
11. Van Den Brule FA, Waltregny D, Castronovo V. Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients. J Pathol 2001;193:80-7. (Pubitemid 32051116)
12. Cindolo L, Benvenuto G, Salvatore P, Pero R, Salvatore G, Mirone V, et al. galectin-1 and galectin-3 expression in human bladder transitional- cell carcinomas. Int J Cancer 1999;84:39-43. (Pubitemid 29059106)
13. Sanjuán X, Fernández PL, Castells A, Castronovo V, van den Brule F, Liu FT, et al. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology 1997;113:1906-15. (Pubitemid 27512149)
14. Szoke T, Kayser K, Baumhakel JD, Trojan I, Furak J, Tiszlavicz L, et al. Prognostic significance of endogenous adhesion/growth-regulatory lectins in lung cancer. Oncology 2005;69:167-74. (Pubitemid 41376916)
15. Vespa GN, Lewis LA, Kozak KR, Moran M, Nguyen JT, Baum LG, et al. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation. J Immunol 1999;162:799-806. (Pubitemid 29035402)
16. Liu SD, Whiting CC, Tomassian T, Pang M, Bissel SJ, Baum LG, et al. Endogenous galectin-1 enforces class I-restricted TCR functional fate decisions in thymocytes. Blood 2008;112:120-30.
17. Kopitz J, von Reitzenstein C, André S, Kaltner H, Uhl J, Ehemann V, et al. Negative regulation of neuroblastoma cell growth by carbohydrate- dependent surface binding of galectin-1 and functional divergence from galectin-3. J Biol Chem 2001;276:35917-23.
18. Tinari N, Kuwabara I, Huflejt ME, Shen PF, Iacobelli S, Liu FT. Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation. Int J Cancer 2001;91:167-72. (Pubitemid 32041735)
19. Van Den Brule FA, Buicu C, Baldet M, Sobel ME, Cooper DN, Marschal P, Castronovo V, et al. Galectin-1 modulates human melanoma cell adhesion to laminin. Biochem Biophys Res Commun 1995;209:760-7.
20. Wu MH, Hong TM, Cheng HW, Pan SH, Liang YR, Hong HC, et al. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons. Mol Cancer Res 2009;7:311-8.
21. Perillo NL, Pace KE, Seilhamer JJ, Baum LG. Apoptosis of T cells mediated by galectin-1. Nature 1995;378:736-9. (Pubitemid 126647279)
22. Yang RY, Liu FT. Galectins in cell growth and apoptosis. Cell Mol Life Sci 2003;60:267-76.
23. Rubinstein N, Alvarez M, Zwirner NW, Toscano MA, Ilarregui JM, Bravo A, et al. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege. Cancer Cell 2004;5:241-51. (Pubitemid 38402116)
24. Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S, et al. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci U S A 2006;103:15975-80. (Pubitemid 44657577)
25. Thijssen VL, Barkan B, Shoji H, Aries IM, Mathieu V, Deltour L, et al. Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res 2010;70:6216-24.
26. Le QT, Shi G, Cao H, Nelson DW, Wang Y, Chen EY, et al. Galectin-1: a link between tumor hypoxia and tumor immune privilege. J Clin Oncol 2005;23:8932-41. (Pubitemid 46211478)
27. Chung CD, Patel VP, Moran M, Lewis LA, Miceli MC. Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction. J Immunol 2000;165:3722-9. (Pubitemid 32057278)
28. Camby I, Le Mercier M, Lefranc F, Kiss R. Galectin-1: a small protein with major functions. Glycobiology 2006;16:137R-57R.
29. Rabinovich GA, Ramhorst RE, Rubinstein N, Corigliano A, Daroqui MC, Kier-Joffé EB, et al. Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms. Cell Death Differ 2002;9:661-70. (Pubitemid 34618872)
30. Le Mercier M, Lefranc F, Mijatovic T, Debeir O, Haibe-Kains B, Bontempi G, et al. Evidence of galectin-1 involvement in glioma chemoresistance. Toxicol Appl Pharmacol 2008;229:172-83.
31. Mathieu V, Le Mercier M, De Neve N, Sauvage S, Gras T, Roland I, et al. Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model. J Invest Dermatol 2007;127:2399-410. (Pubitemid 47619747)
32. Kuo PL, Hung JY, Huang SK, Chou SH, Cheng DE, Jong YJ, et al. Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway. J Immunol 2011;186:1521-30.
33. Giguère D, Bonin MA, Cloutier P, Patnam R, St-Pierre C, Sato S, et al. Synthesis of stable and selective inhibitors of human galectins-1 and -3. Bioorg Med Chem 2008;16:7811-23.
34. Yu X, Siegel R, Roeder RG. Interaction of the B cell-specific transcriptional coactivator OCA-B and galectin-1 and a possible role in regulating BCR-mediated B cell proliferation. J Biol Chem 2006;281:15505-16. (Pubitemid 43855143)
35. Tsai CM, Chiu YK, Hsu TL, Lin IY, Hsieh SL, Lin KI, et al. Galectin-1 promotes immunoglobulin production during plasma cell differentiation. J Immunol 2008;181:4570-9.
36. + memory B cells through altering balances in Bcl-2 family proteins. J Immunol 2009;182:1490-9.
37. Ngo VN, Cornall RJ, Cyster JG. Splenic T zone development is B cell dependent. J Exp Med 2001;194:1649-60. (Pubitemid 33126815)
38. Linton PJ, Harbertson J, Bradley LM. A critical role for B cells in the development of memory CD4 cells. J Immunol 2000;165:5558-65.
39. Melamed D, Miri E, Leider N, Nemazee D. Unexpected autoantibody production in membrane Ig-mu-deficient/lpr mice. J Immunol 2000;165:4353-8.